Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.01 and traded as low as $0.0071. Evofem Biosciences shares last traded at $0.0071, with a volume of 643,430 shares changing hands.
Evofem Biosciences Trading Down 7.8%
The firm has a market capitalization of $940,963.00, a P/E ratio of -0.01 and a beta of -1.30. The company has a 50-day moving average of $0.01 and a 200-day moving average of $0.01.
Evofem Biosciences Company Profile
Evofem Biosciences is a clinical?stage biotechnology company based in San Diego, California, specializing in women’s sexual and reproductive health. Founded in 2013 as a spin-out of the Scripps Research Institute, the company is focused on developing non-hormonal, on-demand products that address unmet needs in contraception and the prevention of sexually transmitted infections.
The company’s lead commercial product, Phexxi, is an FDA-approved, non-hormonal vaginal gel that maintains the vagina’s natural pH to reduce the risk of unintended pregnancy.
Recommended Stories
- Five stocks we like better than Evofem Biosciences
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
